Deirdre B. Hoban

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD

Agnete Kirkeby, Jenny Nelander, Deirdre B. Hoban et al. · Cell stem cell · 2023 · 120 citations · Full text

Cell Therapy, Cell Replacement Therapy, Biomedical Engineering +24

Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson’s disease

Katarína Tiklová, Sara Nolbrant, Alessandro Fiorenzano et al. · Nature Communications · 2020 · 109 citations · Full text

Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat

Deirdre B. Hoban, Emer Connaughton, Catherine Connaughton et al. · Brain Behavior and Immunity · 2012 · 107 citations

Neurodegenerative Diseases, Intra-striatal Lipopolysaccharide Administration, Neurobiology Of Disease +15

hESC-Derived Dopaminergic Transplants Integrate into Basal Ganglia Circuitry in a Preclinical Model of Parkinson’s Disease

Andrew F. Adler, Tiago Cardoso, Sara Nolbrant et al. · Cell Reports · 2019 · 94 citations · Full text

Neurodegenerative Diseases, Medicine, Preclinical Model +11

GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease

Deirdre B. Hoban, Linda Howard, Eilís Dowd · Neuroscience · 2015 · 91 citations

Regenerative Medicine, Mesenchymal Stem Cells, Neurodegenerative Diseases +13